Scout | NOT-AI-22-042: Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP)

This opportunity is no longer accepting applications.

grant NOT-AI-22-042

Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP)

Summary

This grant opportunity aims to fund new projects focused on developing a diverse range of long-acting antiretroviral products for preventing and treating HIV. These products should offer at least three months of protection from either a single dose or a continuous dosing method, such as implants or patches, to align with the current market standards for HIV treatment and prevention.

The purpose of this Notice is to encourage new applications to support further development of a diverse and comprehensive portfolio of SR/LA products for prevention and treatment of HIV. SR/LA antiretroviral products will have a minimum window of protection of three (3) months from either a sing…

Funding Source

Agency: National Institutes of Health

Sub-agency: National Institute of Allergy and Infectious Diseases

Dates

Opportunity Released: April 28, 2022

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers